J.P. Morgan Raises Illumina Price Target To $75 (ILMN)

J.P. Morgan raised its Illumina ILMN price target to $75 from $68 in a research report published today. In the report, J.P. Morgan states, "Coming on the heels of a successful AGBT conference last week, in which ILMN once again had a dominant presence (see our recap note for more details), 4Q results, which had been pre-announced on 1/11, reflected continued strength in the underlying business, offset partially on the bottom line by several factors, including mix from the GAII trade-in program, which weighed on non-GAAP gross margin (65.1%, down 600 bps y/y)." Shares of Illumina were at $69.99 in pre-market trading at the time of posting, down 0.37% from Tuesday's market close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJ.P. MorganLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!